Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

CLI Director of Research David Prentice, Ph.D., Becomes Featured Author for Bioethics Quarterly

The National Catholic Bioethics Quarterly is an invaluable resource not only for insights on ethical issues but news about key developments in medicine and technology.  This summer NCBQ added a new author to its array of resources, a regular update on Science written by Charlotte Lozier Institute Vice President and Director of Research, David Prentice, Ph.D.

 

In this first report, Dr. Prentice provides a series of updates on new findings, and a wealth of good news, from the fields of stem cell research and cloning in animals.  The topics covered include an improved approach to the use of adult stem cells to treat sickle cell anemia in adult human beings, a report on two new publications detailing sustained progress in the use of a patient’s own stem cells to induce remission in multiple sclerosis, and synopses of three studies on effective use of stem cells to repair lung damage.  One particularly interesting use involves success in repairing corneal damage using stem cells taken from dental pulp, as well as stem cells taken from the limbus of the eye.  There is also new evidence that direct cell-type conversion (from, say, liver cell to neural cell) may be possible without “de-differentiation,” that is, taking a cell back to an earlier state of differentiation before steering it into a new cell type with therapeutic potential.

 

Dr. Prentice also describes the challenges new papers reveal, reporting on Japanese researchers who found potential for tumor formation using induced pluripotent stem cells to treat spinal cord injury in mice.  Short-term improvement was followed within a few months by tumor formation at injected sites.  The researchers make suggestions that may reduce or avert this risk, but clearly much remains to be learned about even ethical sources of stem cells as new therapeutic trials in human beings are considered.

 

The summer 2015 of NCBQ offers a wide variety of other articles of note, including attorney William L. Saunders’ review of recent public policy developments in the nation’s capital and summaries of research studies on major topics in ethics and medicine from around the world.   For more information on subscribing to NCBQ, to read sample articles, or to purchase an individual article, visit the website of the National Catholic Bioethics Center here.

 

Charles A. Donovan is president of the Charlotte Lozier Institute.

Latest Posts

June 18, 2024 Written Testimony of Dr. Ingrid Skop on Interstate Travel for Abortion June 3, 2024 Abortion Reporting: Arkansas (2023) May 29, 2024 Abortion Reporting: West Virginia (2023)

You Might Also Be Interested In

A Fact-Free Campaign Against Parents and Unborn Children in Alabama

April 22, 2024
ClosePlease login
Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

Lozier Institute Amicus Brief in Support of Ecuador Law Limiting Abortion

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024
ClosePlease login

Public Comment: Lozier Institute on CDC’s Notice of Proposed Modifications to Assisted Reproductive Technology Program Reporting

charlotte-lozier-institute Charlotte Lozier Institute
February 21, 2024
ClosePlease login

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image